Neurophet AQUA
Overview
Neurophet AQUA is an artificial intelligence-based software solution designed for the quantitative analysis of brain MRI and PET images. It assists clinicians in the diagnosis, treatment planning, and monitoring of various neurodegenerative diseases, including Alzheimer’s disease, mild cognitive impairment, dementia, and multiple sclerosis. The software automates precise segmentation, volumetric quantification of brain structures and lesions, and detection of specific imaging biomarkers such as white matter hyperintensities, cerebral microbleeds, and edema. By providing objective evaluation, normative comparisons (for both Asian and Western populations), and intuitive analysis reports, Neurophet AQUA aims to streamline workflows, reduce manual tasks, and support informed, patient-specific clinical decision-making.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Fast and precise automatic quantification analysis of brain MRI
- Precision brain MRI segmentation and volumetric analysis
- Automated lesion localization and quantification (microbleeds, edema, WMH)
- Quantitative analysis of MRI and PET images (including SUVR)
- Comparison with normative reference data (Asian & Western populations)
- Intuitive analysis reports and visualized graphs
- Multi-time-point and longitudinal analysis for disease progression
- Supports monitoring of treatment efficacy and side effects (e.g., ARIA)
- Integration into standard reading environments (PACS)
- Analysis of Multiple Sclerosis lesions and structural changes
Use Cases
- Diagnosis and differential diagnosis of Alzheimer's disease and dementia
- Monitoring of Alzheimer's disease treatment effects and adverse events (ARIA)
- Evaluation of neurodegeneration and cognitive impairment
- Analysis and monitoring of Multiple Sclerosis progression
- Support for clinical trials and research imaging analysis
- Predicting prognosis from mild cognitive impairment to dementia
What Physicians Need to Know
Neurophet AQUA offers rapid and accurate quantitative analysis of brain MRI and PET images, which can significantly aid in the early diagnosis, staging, and monitoring of neurodegenerative diseases like Alzheimer's and Multiple Sclerosis. The automated segmentation and volumetric analysis, including white matter hyperintensities and microbleeds, can support treatment management and help assess treatment-related side effects. The software's ability to provide normative comparisons and longitudinal analysis can be valuable for tracking disease progression and treatment efficacy.
Neurophet AQUA is designed to integrate into standard reading environments such as PACS. The company is actively discussing with radiology AI solution platform companies to supply its products to the US market.
Details
| Category | Neurology AI, Radiology & Imaging AI |
| Pricing | One-off payment, subscription, pay-per-scan |
| Deployment | Locally on dedicated hardware |
| Compliance | |
| BAA Available | Unknown |
| HIPAA Compliant | Unknown |
| FDA Status | Cleared AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | Neurology, Nuclear Medicine, Radiology |
FDA clearance history
This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.
| Decision date | Number | Name as listed by FDA |
| 2024-10-25 | K242215 510(k) | Neurophet AQUA |
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate Neurophet AQUA
Videos
Product demos, reviews, and walkthroughs for Neurophet AQUA.
[Brand Film] Neurophet explores the brain
Neurophet





